glp 1 drugs and alcohol GLP-1s Hold Promise as Treatment for Use Disorder GLP-1 Weight Loss and Alcohol:
Description
Although the increase is typically small, it may be clinically relevant in patients with existing arrhythmias
Supply : In 2025, supply bottlenecks will continue to ease following extensive efforts by Novo Nordisk and Lilly to step up manufacturing, with important implications for competitive dynamics: The large-scale opportunity for compounders will be closing
Mannucci E, Mannucci DE
Duah J, Seifer D
